38 results
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
2 May 24
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
6:03am
barriers to care among LN patients, (Diversity, Equity and Inclusion) DE&I practices, employee engagement, and risk management. The full report is available
DEFA14A
uq5hh2mfbj
18 Apr 22
Additional proxy soliciting materials
7:36am
S-8
EX-10.1
qwv5xzfe13y
25 Jun 21
Registration of securities for employees
4:31pm
8-K
EX-99.1
iul2po3m040hxhl1
10 Jun 21
Departure of Directors or Certain Officers
4:08pm
DEF 14A
ai075
10 May 21
Definitive proxy
4:06pm
PRE 14A
6rj lykkz
27 Apr 21
Preliminary proxy
4:32pm
8-K
EX-3.2
2gsg0i aqk2s5s
27 Apr 21
Amendments to Articles of Incorporation or Bylaws
4:17pm
10-K
EX-10.17
dozgk3m
24 Feb 21
Annual report
4:09pm
8-K
EX-99.2
zauo 0ztj1h1x
25 Jan 21
Financial Statements and Exhibits
8:21am
8-K
EX-99.1
g4v6k56
25 Jan 21
Financial Statements and Exhibits
8:21am
6-K
EX-99.2
24ueci dm9
30 Dec 20
Material Change Report
5:30pm
6-K
EX-99.1
s9tiyc
14 Oct 20
Aurinia Pharmaceuticals Inc. 6-K
6:10am
6-K
EX-99.1
cmp3ep
11 Aug 20
Aurinia Pharmaceuticals Inc. 6-K
4:02pm
S-8
EX-4.2
bp1vhvd
9 Jun 20
Registration of securities for employees
4:57pm